The association between low sex hormone binding globulin and increased risk of type 2 diabetes is mediated by increased visceral and liver fat: results from observational and Mendelian randomization analyses.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 09 07 2024
accepted: 29 07 2024
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: aheadofprint

Résumé

The aim of this study was to investigate the associations between sex hormone binding globulin (SHBG), visceral fat (VAT), liver fat content, and risk of type 2 diabetes. In the Netherlands Epidemiology of Obesity study 5690 women (53%) and men without pre-existing diabetes were included and followed for incident type 2 diabetes. SHBG concentrations were measured in all, VAT with MRI, and liver fat content with proton-MR spectroscopy in n=1822. We examined associations between SHBG and liver fat with linear regression and bidirectional Mendelian randomization analyses, and between SHBG and type 2 diabetes with Cox regression adjusted for confounding, and additionally for VAT and liver fat to examine mediation. The mean(SD) age was 56(6) years, BMI 30(4) kg/m2, median(IQR) SHBG was 47 (34,65) nmol/L in women and 34 (26,43) nmol/L in men, median(IQR) liver fat was 3.4(1.6,8.2)% in women and 6.0 (2.9,13.5)% in men. Compared with the highest SHBG quartile, liver fat was 2.9-fold (95%CI: 2.4,3.4) increased in women and 1.6-fold (95%CI: 1.3,1.8) in men, and the hazard ratio (95%CI) of type 2 diabetes was 4.9 (2.4,9.9) in women and 1.8 (1.1,2.9) in men. Genetically predicted SHBG was associated with liver fat content (women: SD (95%CI) -0.45(-0.55,-0.35), men: ln(95%CI) -0.25 (-0.34,-0.16)). VAT and liver fat together mediated 43% (women) and 60% (men) of the SHBG-type 2 diabetes association. To conclude, in a middle-aged population with overweight, the association between low SHBG and increased risk of type 2 diabetes was for a large part mediated by increased VAT and liver fat.

Identifiants

pubmed: 39106187
pii: 157057
doi: 10.2337/db23-0982
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the American Diabetes Association.

Auteurs

Theresa A Stangl (TA)

Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology & Metabolism, De Boelelaan 1117, Amsterdam, The Netherlands.

Chantal M Wiepjes (CM)

Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology & Metabolism, De Boelelaan 1117, Amsterdam, The Netherlands.

Roelof A J Smit (RAJ)

Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, 10029 NY, New York, USA.

Astrid van Hylckama Vlieg (A)

Leiden University Medical Center, Department of Clinical Epidemiology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Hildo J Lamb (HJ)

Leiden University Medical Center, Department of Radiology, Albinusdreef 2, 2333 ZA Leiden.

Jeroen H P M van der Velde (JHPM)

Leiden University Medical Center, Department of Clinical Epidemiology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Esther Winters van Eekelen (E)

Leiden University Medical Center, Department of Clinical Epidemiology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Sebastiaan C Boone (SC)

Leiden University Medical Center, Department of Clinical Epidemiology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Martijn C G J Brouwers (MCGJ)

Division of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Frits R Rosendaal (FR)

Leiden University Medical Center, Department of Clinical Epidemiology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Martin den Heijer (M)

Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology & Metabolism, De Boelelaan 1117, Amsterdam, The Netherlands.

Annemieke C Heijboer (AC)

Amsterdam UMC, location Vrije Universiteit Amsterdam and location University of Amsterdam, Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam Gastroenterology Endocrinology & Metabolism, Amsterdam Reproduction & Development, De Boelelaan 1117 and Meibergdreef 9, Amsterdam, The Netherlands.

Renée de Mutsert (R)

Leiden University Medical Center, Department of Clinical Epidemiology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Classifications MeSH